Table 3.
Response~ | AUC [95%CI] | pa | Sensitivity | Specificity | PPV | NPV | Accuracy |
---|---|---|---|---|---|---|---|
ALPL | 0.589 [0.505;0.673] | 0.04 | 0.68 | 0.56 | 0.70 | 0.54 | 0.63 |
DHRS13 | 0.613 [0.533;0.693] | 0.008 | 0.46 | 0.75 | 0.73 | 0.48 | 0.57 |
HOMER3 | 0.604 [0.524;0.685] | 0.01 | 0.65 | 0.56 | 0.69 | 0.51 | 0.61 |
DGAT2 | 0.634 [0.555;0.713] | 0.002 | 0.37 | 0.85 | 0.79 | 0.47 | 0.56 |
WLS | 0.608 [0.527;0.688] | 0.01 | 0.56 | 0.67 | 0.72 | 0.50 | 0.60 |
CA4 | 0.622 [0.543;0.702] | 0.005 | 0.50 | 0.72 | 0.73 | 0.49 | 0.59 |
ALPL*DHRS13*HOMER3 *DGAT2*WLS*CA4 | 0.791 [0.728;0.853] | 0.77 | 0.77 | 0.68 | 0.78 | 0.66 | 0.73 |
Age+Sex+DUP+PPANSS | 0.716 [0.640;0.791] | 0.0001 | 0.74 | 0.67 | 0.77 | 0.63 | 0.71 |
ALPL+Age+Sex+DUP+PPANSS | 0.751 [0.678;0.824] | <10−4 | 0.73 | 0.73 | 0.80 | 0.64 | 0.73 |
DHRS13+Age+Sex+DUP+PPANSS | 0.740 [0.666;0.813] | <10−4 | 0.88 | 0.51 | 0.73 | 0.75 | 0.73 |
HOMER3+Age+Sex+DUP+PPANSS | 0.722 [0.647;0.797] | <10−4 | 0.71 | 0.73 | 0.80 | 0.62 | 0.72 |
DGAT2+Age+Sex+DUP+PPANSS | 0.743 [0.670;0.816] | <10−4 | 0.65 | 0.77 | 0.81 | 0.60 | 0.70 |
WLS+Age+Sex+DUP+PPANSS | 0.738 [0.664;0.812] | <10−4 | 0.82 | 0.63 | 0.77 | 0.70 | 0.74 |
CA4+Age+Sex+DUP+PPANSS | 0.741 [0.669;0.812] | <10−4 | 0.59 | 0.81 | 0.83 | 0.57 | 0.68 |
ALPL*DHRS13*HOMER3 *DGAT2*WLS*CA4+Age+Sex+DUP+PPANSS | 0.938 [0.905;0.971] | 0.02 | 0.88 | 0.89 | 0.92 | 0.84 | 0.89 |
AUC area under the curve, CI confidence interval, DUP duration of untreated psychosis, NPV negative predictive value, PPANSS positive PANSS score, PPV positive predictive value.
ap values have been estimated after 10,000 permutations of the response status in 188 individuals.